New sunscreen option wins FDA approval after years of delay
Summary
The FDA has approved a new sunscreen ingredient called bemotrizinol, the first new addition in more than 25 years. This ingredient has been used safely in Europe and will offer better protection against harmful sun rays without causing irritation or leaving a white residue.Key Facts
- Bemotrizinol protects against both UVA (causes skin cancer and wrinkles) and UVB rays (cause sunburn).
- It is safe for adults and children 6 months and older.
- The ingredient will be sold in the U.S. first by Dutch company DSM under the brand Parsol Shield later this year.
- After 18 months of exclusive sales by DSM, other companies can use bemotrizinol in their products.
- Bemotrizinol has been used in Europe since 1999 and was first submitted for FDA approval in 2005.
- The FDA’s 2020 streamlined process helped speed up the ingredient’s approval after decades of delays.
- Current U.S. sunscreens either protect against UVA or UVB, but bemotrizinol protects against both without leaving chalky white marks.
- The FDA has been updating sunscreen rules gradually, including banning the term “waterproof” and requiring broad UVA and UVB protection.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.